China Beefs Up Quality Control System With New GMP Regulations: Shanghai FDA Leaders At PharmAsia Summit
This article was originally published in PharmAsia News
Executive Summary
SAN FRANCISCO - China is releasing a new edition of its good manufacturing practice regulations and introducing other measures to strength its pharmaceutical quality control system. China's State FDA is placing more focus on reviewing drugs for approval while provincial-level regulators have stepped-up responsibility for inspecting drug makers and monitoring drugs on the market, said Shanghai FDA officers who spoke at the PharmAsia Summit this week in San Francisco